Advertisement
Skip to Content

Bristol-Myers Squibb Co BMY Stock Quote

| Rating as of

NYSE: BMY

Last close prices updated as of Feb 06, 2023, 7:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 74.53
  • Sector Healthcare
  • Industry Drug Manufacturers - General
  • Investment Style Large Value
  • Day Range 74.23  –  75.18
  • Year Range 65.00  –  81.44
  • Market Cap 158.4627 Bil
  • Volume / Avg 7.1 Mil /  9.0 Mil
  • Price / Sales 3.47
  • Price / Book 4.64
  • Forward Div Yield 3.06%
  • Trailing Div Yield 2.94%

Morningstar‘s Stock Analysis BMY

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Bristol Posts Solid Q4 as Core Drugs Help Mitigate Generics, but Long-Term Growth Looks Challenging

Damien Conover Sector Director

Analyst Note

| Damien Conover |

Bristol-Myers Squibb reported fourth-quarter results and issued 2023 guidance that ran a bit higher than our expectations, but we don’t expect any major changes to our fair value estimate based on the minor outperformance. With one of the heaviest patent pressures in the industry, Bristol is navigating the current generic headwinds well while also preparing for significant patent losses of Opdivo (cancer drug) and Eliquis (cardiovascular drug) in 2028, giving us confidence in the firm’s wide moat.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics BMY

Company Profile BMY

Business Description

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Contact
430 East 29th Street, 14th Floor
New York, NY, 10016
Industry Drug Manufacturers - General
Employees 32,200

Related Articles BMY

FAQs for Bristol-Myers Squibb Co Stock

Yes. BMY has a forward dividend yield of 3.06%. See BMY’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

BMY’s market cap is 158.46 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

BMY’s stock style is Large Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

BMY’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare BMY’s historical performance against its industry peers and the overall market.